U.S. Food and Drug Administration

Taylor Farms manages expanding Cyclospora and Salmonella

50 clusters · 1148 sources · last updated about 20 hours ago

Latest: U.S. officials to declare end of record cyclosporiasis outbreak

Taylor Farms continues to manage two distinct food safety crises involving Cyclospora and Salmonella. The Cyclospora cayetanensis outbreak, linked to shredded iceberg lettuce from central Mexico, has reached unprecedente

U.S. food safety and outbreak concerns

3 clusters · 17 sources · last updated 1 day ago

Latest: Listeria contamination triggers food recalls in Chile and the United States

In August 2026, several major food recalls were issued in the United States due to bacterial risks and physical contamination. These included a nationwide voluntary recall of Outshine Fruit Bars by Dreyer’s Grand Ice Cre

Skincare and makeup application techniques

4 clusters · 11 sources · last updated 1 day ago

Latest: Beauty and skincare tips for women over 50

Beauty experts recommend foundational skincare habits to improve makeup application, such as washing with a gentle cleanser and applying moisturizer to damp skin. The daily use of broad-spectrum sunscreen with SPF 30 or

GLP-1 drugs: clinical trends, safety, and market shifts

246 clusters · 894 sources · last updated 1 day ago

Latest: Medical experts propose management system for GLP-1 obesity drugs

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr

FDA, Japan, and China approve Orzeyful for narcolepsy

4 clusters · 9 sources · last updated 2 days ago

Latest: Orzeyful receives global approvals for narcolepsy type 1 treatment

The U.S. Food and Drug Administration has approved Takeda’s Orzeyful (oveporexton), the first oral orexin-2 receptor agonist for adults with narcolepsy type 1. Unlike previous treatments that manage symptoms, Orzeyful ta

Samsung Galaxy Watch 9 & Ultra 2: Features and Hardware News

57 clusters · 501 sources · last updated 2 days ago

Latest: Samsung launches Galaxy Watch9 with AI health features

Following the July 2026 launch, Samsung introduced the Galaxy Watch 9 and Galaxy Watch Ultra 2, featuring the Snapdragon Wear Elite platform and Wear OS 7. The devices emphasize AI-driven health intelligence, including a

U.S. legal challenges to mifepristone access

2 clusters · 20 sources · last updated 2 days ago

Latest: 5th U.S. Circuit Court hears arguments over mifepristone access

Legal challenges regarding the nationwide availability of the abortion medication mifepristone have progressed through the U.S. federal court system. In late August, U.S. Chief District Judge Reed O’Connor paused a fede

Health risks and management of added sugar consumption

8 clusters · 28 sources · last updated 2 days ago

Latest: Health benefits of reducing added sugar consumption

Health concerns regarding high fructose corn syrup (HFCS) and added sugars focus on their role in obesity, metabolic syndrome, diabetes, and inflammation. HFCS is produced by converting glucose into fructose through corn

Juul Labs FDA regulatory developments

3 clusters · 11 sources · last updated 3 days ago

Latest: US vaping market sees new product launches and regulatory shifts

Juul Labs has faced long-term regulatory scrutiny from the U.S. Food and Drug Administration (FDA) regarding its products and flavored pods. Following the 2019 removal of popular flavors and subsequent marketing denial o

FDA authorization of Aletta robotic blood draw device

4 clusters · 21 sources · last updated 3 days ago

Latest: Vitestro’s Aletta receives FDA authorization for autonomous blood collection

The U.S. Food and Drug Administration (FDA) has granted De Novo authorization to Aletta, an autonomous robotic system developed by the Dutch company Vitestro for performing blood draws on adult patients in outpatient set

Eli Lilly retatrutide development and black market issues

8 clusters · 26 sources · last updated 3 days ago

Latest: Retatrutid shows significant weight loss in Phase 3 trials

In early August 2026, Eli Lilly announced that its experimental obesity treatment retatrutide achieved substantial weight-loss outcomes in two phase-3 trials. Participants lost up to 22.6% of body weight over 80 weeks in

Youth nicotine health concerns and global regulatory shifts

44 clusters · 161 sources · last updated 4 days ago

Latest: Philip Morris International expands Zyn portfolio following FDA approval

Research in 2026 continues to link adolescent nicotine use to serious disease. Two cases of terminal lung cancer in women who began vaping at age 15 were reported in the UK, underscoring emerging clinical evidence of sev

Health risks from seafood mercury and toxins

3 clusters · 6 sources · last updated 5 days ago

Latest: Health risks of consuming certain fish types

Health concerns regarding seafood consumption have been highlighted through data on mercury accumulation and natural toxins in various fish species. FDA data identifies specific species with high methylmercury content,

Global regulatory progress for MDMA-assisted therapy

3 clusters · 27 sources · last updated 6 days ago

Latest: New Zealand approves MDMA for clinical PTSD treatment

Regulatory developments regarding MDMA-assisted therapy for post-traumatic stress disorder (PTSD) have progressed in both the United States and New Zealand. In the United States, Resilient Pharmaceuticals resubmitted a

RFK Jr. HHS leadership, vaccine policy & CDC turmoil

57 clusters · 256 sources · last updated 6 days ago

Latest: Robert F. Kennedy Jr. appoints adviser to investigate military vaccine deaths

Since his April 2026 appointment, HHS Secretary Robert F. Kennedy Jr. has reshaped U.S. health governance, installing acting heads at the CDC, NIH, FDA and the Surgeon‑General’s office. He issued rules on ultra‑processed

Kratom regulation and safety in the United States

4 clusters · 21 sources · last updated 6 days ago

Latest: Kratom regulation debates intensify in Pennsylvania and New York

Kratom occupies a complex regulatory position in the United States. While the FDA has not scheduled the botanical product, it has stated that no kratom-containing products are legally marketed as prescription drugs, over

AI healthcare integration expands via agents, robotics, and

16 clusters · 77 sources · last updated 7 days ago

Latest: AI and cybersecurity pose growing risks to patient privacy in hospitals

Since the July 2026 summit, AI deployment in healthcare has accelerated toward a collaborative model. While AI automates repetitive tasks, experts emphasize that human judgment remains essential for medical coding, clini

Medline Inc. securities and FDA investigation

2 clusters · 3 sources · last updated 8 days ago

Latest: Kaplan Fox investigates multiple companies for potential securities violations

Medline Inc. is under investigation by the law firm Kaplan Fox & Kilsheimer LLP regarding potential securities law violations. This legal scrutiny follows regulatory actions by the U.S. Food and Drug Administration (FDA)

US military testosterone testing policy

2 clusters · 27 sources · last updated 9 days ago

Latest: Pentagon issues testosterone screening guidelines for troops

The U.S. Department of Defense has moved from proposing to mandating a new policy regarding testosterone testing for military personnel. Initially, the Department of Defense proposed monitoring testosterone levels to sup

South Korean food industry expansion and export trends

4 clusters · 7 sources · last updated 10 days ago

Latest: South Korean food producers expand export reach to Europe and North America

South Korean food and beverage companies are aggressively expanding their presence in the North American market, particularly in the United States, to offset declining domestic consumption. Initial efforts have focused o

Alfalfa sprout foodborne illness outbreak in the US

5 clusters · 41 sources · last updated 10 days ago

Latest: Everything Sprouts expands recall to include radish sprout mix

U.S. health officials have linked a multistate outbreak of E. coli and Salmonella to alfalfa sprouts produced by Everything Sprouts LLC of Minneapolis. The outbreak has sickened at least 55 people across 15 states, resul

Samsung Galaxy Buds evolution and new hearing aid features

10 clusters · 77 sources · last updated 11 days ago

Latest: Samsung Galaxy Buds4 Pro wins EISA In-Ear Headphones award

In early July 2026, reviews of Samsung’s Galaxy Buds 4 and Buds 4 Pro highlighted AI-driven features and upgraded active noise cancellation. By month-end, leaks suggested two new models: a clip-on, open-ear design (coden

FDA approval of bemotrizinol sunscreen ingredient

3 clusters · 6 sources · last updated 11 days ago

Latest: Bemotrizinol approved by FDA as first new U.S. sunscreen active in decades

The U.S. Food and Drug Administration (FDA) has authorized the use of bemotrizinol (BEMT) in over-the-counter sunscreen products. This marks the first new active ingredient added to the American approved list since the l

FDA approval of Moderna mRNA influenza vaccine

3 clusters · 6 sources · last updated 11 days ago

Latest: FDA approves first mRNA influenza vaccine as regional vaccination efforts expand

The U.S. Food and Drug Administration (FDA) has approved Moderna’s mFLUSIVA, the first mRNA-powered influenza vaccine. This technology utilizes a genetic blueprint to produce viral proteins, offering a faster production

FDA approval of Mounjaro for cardiovascular risk

2 clusters · 16 sources · last updated 12 days ago

Latest: FDA approves Eli Lilly's Mounjaro to reduce heart attack and stroke risk

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s diabetes medication, Mounjaro (tirzepatide), to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who are at

Deramiocel trial, FDA pivot, and ongoing lawsuit

5 clusters · 21 sources · last updated 14 days ago

Latest: Capricor Therapeutics pivots regulatory strategy amid legal challenges

Capricor Therapeutics is navigating a shifting regulatory and strategic landscape following an FDA advisory committee vote against the original effectiveness case for deramiocel in treating Duchenne cardiomyopathy. In re

Health impact of natural dairy fats research

2 clusters · 2 sources · last updated 15 days ago

Latest: Dairy trans fats differ from industrial types in health impact

Research published in the journal ‘Nutrition Research’ indicates that natural dairy fats do not appear to increase the risk of cardiovascular disease, stroke, or type 2 diabetes. An initial analysis of 22 studies across

U.S. cereal manufacturers removing artificial dyes

2 clusters · 19 sources · last updated 16 days ago

Latest: General Mills removes artificial dyes from all U.S. cereals

Major U.S. cereal manufacturers are transitioning away from synthetic food additives in response to consumer and political pressure. In early August, WK Kellogg announced it would accelerate its timeline to remove all a

Cyclospora outbreak and food safety response

2 clusters · 2 sources · last updated 16 days ago

Latest: Health expert warns of foodborne infection risks from lettuce and ice

Following a significant Cyclospora outbreak in the United States linked to iceberg lettuce from Central Mexico, the FDA finalized new guidance for the preparation and packaging of fresh-cut produce. The outbreak, which a

Seafood nutritional benefits and mercury risks

5 clusters · 13 sources · last updated 17 days ago

Latest: Sardines identified by nutritionists as top canned fish choice

Nutritional research continues to highlight the health benefits of consuming small fish and mollusks, such as sardines, sprats, herring, mackerel, oysters, mussels, and clams. These species are rich in iron, zinc, vitami